Document is current
Any future updates will be listed below
-
Authors
Nieskens, Tom T. G.
Magnusson, Otto
Andersson, Patrik
Söderberg, Magnus
Persson, Mikael
Sjögren, Anna-Karin https://orcid.org/0000-0002-5967-3440
-
Funding
Funding for this research was provided by:
AstraZeneca Postdoc Programme (-)
- License Information
-
More Information
Article History
Received: 12 April 2021
Accepted: 28 April 2021
First Online: 7 May 2021
Declarations
:
: Tom Nieskens, Otto Magnusson, Magnus Söderberg, Patrik Andersson, Mikael Persson and Anna-Karin Sjögren are employees of AstraZeneca.
: Human-derived renal proximal tubule epithelial cells (HRPTEC) used in this study were commercially obtained from Biopredic as ‘cryopreserved human renal proximal tubular cells’, reference code ‘RPT101’, batch ‘RPT101030’.
: The data produced in this study utilized human-derived cells that were procured from Biopredic, which provides de-identified samples, and stored in the AstraZeneca BioBank Gothenburg.
